You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Phone

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma, Ovarian Serous Adenocarcinoma Trial in United Kingdom, United

Active, not recruiting
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Huntsville, Alabama
  • +507 more
Dec 27, 2021

T Cell Lymphoma Trial in Seoul (ACHOP)

Not yet recruiting
  • T Cell Lymphoma
  • Seoul, Korea, Republic of
    81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Apr 18, 2022

Clear Cell Renal Cell Carcinoma Trial in Korea, Republic of, United States (X4P-001, axitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +19 more
Sep 20, 2021

Diabetes, Red Blood Cell Survival Trial in Iowa City (biotin labeled RBCs)

Completed
  • Diabetes
  • Red Blood Cell Survival
  • biotin labeled RBCs
  • Iowa City, Iowa
    University of Iowa
Feb 4, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
Jan 13, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Stroke Trial in Grenoble (Adipose Derived Stem Cells, Vehicle media)

Withdrawn
  • Stroke
  • Adipose Derived Stem Cells
  • Vehicle media
  • Grenoble, France
    University Grenoble Hospital / EFS
Sep 28, 2021

Oral Hygiene, Dental Plaque Induced Gingivitis Trial in Quetta (Mobile Phone Messaging)

Completed
  • Oral Hygiene
  • Dental Plaque Induced Gingivitis
  • Mobile Phone Messaging
  • Quetta, Balochistan, Pakistan
  • +1 more
Feb 10, 2021

Fatigue, Sleep Deprivation, Depression Trial in Portland (Protected time and Dedicated time)

Terminated
  • Fatigue
  • +2 more
  • Protected time and Dedicated time
  • Portland, Oregon
    Providence St. Vincent Medical Center
Sep 24, 2019

Predict Efficacy of GC in Treatment of Intrahepatic

Not yet recruiting
  • Organoids
  • Intrahepatic Cholangiocarcinoma
  • gemcitabine + cisplatin
  • (no location specified)
Nov 30, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Epithelial Ovarian Cancer Trial in Singapore (Oregovomab, Nivolumab, Chemotherapy)

Unknown status
  • Epithelial Ovarian Cancer
  • Singapore, Singapore
  • +1 more
Nov 30, 2021

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

Head Neck Cancer Trial in Boston (Radiation therapy)

Recruiting
  • Head and Neck Cancer
  • Radiation therapy
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 14, 2022

Acute-On-Chronic Liver Failure Trial in Germany (allo-APZ2-ACLF)

Terminated
  • Acute-On-Chronic Liver Failure
  • allo-APZ2-ACLF
  • Dresden, Germany
  • +4 more
Nov 9, 2021

Sickle Cell Disease Trial in Boston (BEAM-101)

Not yet recruiting
  • Sickle Cell Disease
  • BEAM-101
  • Boston, Massachusetts
    Boston Children's Hospital
Jul 11, 2022

Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

Active, not recruiting
  • Squamous Non-small Cell Lung Cancer
  • Nivolumab 10 MG/ML Intravenous Solution
  • Best Supportive Care
  • Imola, Bologna, Italy
  • +30 more
Sep 30, 2022

Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory DLBCL Trial in Spain, United Kingdom, United States

Completed
  • Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Marietta, Georgia
  • +27 more
Feb 4, 2022

Type 1 Diabetes Trial in Edmonton (Implantation of Nylon catheter (Device-less sentinel unit))

Recruiting
  • Type 1 Diabetes
  • Implantation of Nylon catheter (Device-less sentinel unit)
  • Edmonton, Alberta, Canada
    University of Alberta Clinical Islet Transplant Program
May 10, 2022

Sexually Transmitted Infections Trial in Cincinnati (Call when test results are ready, Text message when test results are ready,

Completed
  • Sexually Transmitted Infections
  • Call when test results are ready
  • +2 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Sep 14, 2020

Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

Completed
Has Results
  • Hemophagocytic Lymphohistiocytosis
  • +5 more
  • Hematopoietic Stem Cell Transplant
  • Birmingham, Alabama
  • +21 more
Dec 6, 2022

Lung Cancer, Nonsmall Cell Trial (Immunonutrition, Control dietary intervention)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Immunonutrition
  • Control dietary intervention
  • (no location specified)
May 18, 2022

Early Signs of Parkinsons Disease in IBS

Recruiting
  • Parkinson Disease
  • Irritable Bowel Syndrome
    • Örebro, Sweden
      Campus USÖ, Örebro University
    Oct 5, 2022

    Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Locally Advanced Malignant Solid Tumor Trial run by the NCI (p97

    Withdrawn
    • Aggressive Non-Hodgkin Lymphoma
    • +3 more
    • p97 Inhibitor CB-5339 Tosylate
    • Bethesda, Maryland
    • +1 more
    Aug 27, 2021

    Palliative Thoracic ImmunoRT

    Recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer
    • Radiation combined with immunotherapy
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Cancer Centre
    Oct 1, 2021